These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 8306654)

  • 1. Reaction rate in cats vaccinated with a new controlled-titer feline panleukopenia-rhinotracheitis-calicivirus-Chlamydia psittaci vaccine.
    Starr RM
    Cornell Vet; 1993 Oct; 83(4):311-23. PubMed ID: 8306654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-year duration of immunity in cats following vaccination against feline rhinotracheitis virus, feline calicivirus, and feline panleukopenia virus.
    Gore TC; Lakshmanan N; Williams JR; Jirjis FF; Chester ST; Duncan KL; Coyne MJ; Lum MA; Sterner FJ
    Vet Ther; 2006; 7(3):213-22. PubMed ID: 17039444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Questions long-term immunity in cats.
    Norsworthy GD
    J Am Vet Med Assoc; 1999 Aug; 215(3):316-7. PubMed ID: 10434959
    [No Abstract]   [Full Text] [Related]  

  • 4. Onset of immunity in kittens after vaccination with a non-adjuvanted vaccine against feline panleucopenia, feline calicivirus and feline herpesvirus.
    Jas D; Aeberlé C; Lacombe V; Guiot AL; Poulet H
    Vet J; 2009 Oct; 182(1):86-93. PubMed ID: 18694649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Questions efficacy of vaccinating cats at 3-year intervals.
    Norsworthy GD
    Am J Vet Res; 1999 Aug; 60(8):918-9. PubMed ID: 10451196
    [No Abstract]   [Full Text] [Related]  

  • 6. More on efficacy of vaccinating cats at 3-year intervals.
    Ellis JA
    Am J Vet Res; 1999 Sep; 60(9):1035-6. PubMed ID: 10490067
    [No Abstract]   [Full Text] [Related]  

  • 7. Feline panleukopenia virus, feline herpesvirus-1 and feline calicivirus antibody responses in seronegative specific pathogen-free kittens after parenteral administration of an inactivated FVRCP vaccine or a modified live FVRCP vaccine.
    Lappin MR
    J Feline Med Surg; 2012 Feb; 14(2):161-4. PubMed ID: 22314095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term immunity in cats vaccinated with an inactivated trivalent vaccine.
    Scott FW; Geissinger CM
    Am J Vet Res; 1999 May; 60(5):652-8. PubMed ID: 10328440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feline panleukopenia virus, feline herpesvirus-1, and feline calicivirus antibody responses in seronegative specific pathogen-free cats after a single administration of two different modified live FVRCP vaccines.
    Lappin MR; Veir J; Hawley J
    J Feline Med Surg; 2009 Feb; 11(2):159-62. PubMed ID: 18782676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a feline viral rhinotracheitis-feline calicivirus disease vaccine.
    Scott FW
    Am J Vet Res; 1977 Feb; 38(2):229-34. PubMed ID: 190925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feline rhinotracheitis-calici vaccine and feline rhinotracheitis-calici-panleukopenia vaccine: field evaluation for safety.
    Clark WB; Diegmann FG; McIntosh DK; Stiles JA; Slater EA
    Vet Med Small Anim Clin; 1980 Mar; 75(3):415-20. PubMed ID: 6246668
    [No Abstract]   [Full Text] [Related]  

  • 12. The efficacy of two commercial feline rhinotracheitis-calicivirus-panleukopenia vaccines.
    Povey RC
    Can Vet J; 1979 Oct; 20(10):253-60. PubMed ID: 232426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined administration in a single injection of a feline multivalent modified live vaccine against FHV, FCV, and FPLV together with a recombinant FeLV vaccine is both safe and efficacious for all four major feline viral pathogens.
    Kanellos T; Sutton DJ; Salisbury CF; Chalmers WS
    J Feline Med Surg; 2008 Aug; 10(4):346-54. PubMed ID: 18448375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experiences with a new cat coryza-panleukopenia-rabies combined vaccine].
    Franke V; Danner K
    Tierarztl Prax; 1990 Dec; 18(6):629-32. PubMed ID: 1964252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of autoantibodies that bind to kidney tissues in cats and association risk with antibodies to feline viral rhinotracheitis, calicivirus, and panleukopenia.
    Songaksorn N; Petsophonsakul W; Pringproa K; Lampang KN; Sthitmatee N; Srifawattana N; Piyarungsri K; Thongkorn K
    J Vet Sci; 2021 May; 22(3):e38. PubMed ID: 34056879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody response to an inactivated vaccine for rhinotracheitis, caliciviral disease, and panleukopenia in nondomestic felids.
    Bush M; Povey RC; Koonse H
    J Am Vet Med Assoc; 1981 Dec; 179(11):1203-5. PubMed ID: 6276346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A field trial to assess the effect of vaccination against feline herpesvirus, feline calicivirus and feline panleucopenia virus in 6-week-old kittens.
    Dawson S; Willoughby K; Gaskell RM; Wood G; Chalmers WS
    J Feline Med Surg; 2001 Mar; 3(1):17-22. PubMed ID: 11716626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of a recombinant FeLV vaccine combined with a live feline rhinotracheitis, calicivirus and panleukopenia vaccine.
    Gueguen S; Martin V; Bonnet L; Saunier D; Mähl P; Aubert A
    Vet Rec; 2000 Mar; 146(13):380-1. PubMed ID: 10803986
    [No Abstract]   [Full Text] [Related]  

  • 19. Vaccination against feline viral rhinotracheitis in kittens with maternally derived feline viral rhinotracheitis antibodies.
    Johnson RP; Povey RC
    J Am Vet Med Assoc; 1985 Jan; 186(2):149-52. PubMed ID: 2982774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of tri-combinant vaccine for feline herpesvirus, calicivirus and panleukopenia virus infections in Japanese native cats.
    Yagami K; Furukawa T; Fukui M; Hamada H
    Jikken Dobutsu; 1985 Jul; 34(3):287-94. PubMed ID: 2998830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.